Theralase Technologies Inc (TLT) - Product Pipeline Analysis, 2017 Update

Summary

Theralase Technologies Inc (Theralase) is a medical equipment company that designs, develops and manufactures laser and laser technology for human, companion animal and equine applications. The company offers products such as controller, multiple probe, triple probe, single probe, multiple probe, acu-point locator, stand, hard carrying case, laser safety eyewear, laser safety eye cups, laser probe, and protective covers, among others. Its lasers products find application in treating acute and chronic pain conditions, addictions and cosmetic revitalization. The company sells its products through a network of distributors in Canada, the US and internationally. Theralase is headquartered in Toronto, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Theralase Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Theralase Technologies Inc Company Overview 4
Theralase Technologies Inc Company Snapshot 4
Theralase Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Theralase Technologies Inc Pipeline Analysis Overview 7
Theralase Technologies Inc - Key Facts 7
Theralase Technologies Inc - Major Products and Services 8
Theralase Technologies Inc Pipeline Products by Development Stage 9
Theralase Technologies Inc Ongoing Clinical Trials by Trial Status 11
Theralase Technologies Inc Pipeline Products Overview 13
TLC-2000 Therapeutic Medical Laser System 13
TLC-2000 Therapeutic Medical Laser System Product Overview 13
TLC-3200 Medical Laser 14
TLC-3200 Medical Laser Product Overview 14
TLC-3200 Medical Laser Clinical Trial 15
TLC-3400 Medical Laser 16
TLC-3400 Medical Laser Product Overview 16
Theralase Technologies Inc - Key Competitors 17
Theralase Technologies Inc - Key Employees 18
Theralase Technologies Inc - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Theralase Technologies Inc, Recent Developments 20
Nov 30, 2017: Theralase Discovers Theralase Cold Laser Therapy Enhances Cancer Destruction for Standard Cancer Treatments 20
Nov 29, 2017: Theralase Increases Revenue 12% for 3Q2017 Financial Statements 22
Nov 27, 2017: Theralase Therapeutic Laser Technology Enhances Cancer Destruction 24
Aug 29, 2017: Theralase Increases Revenue 14% for 2Q2017 Financial Statements 26
Aug 01, 2017: Theralase PDT Technology Used to Treat Fourth Patient for Bladder Cancer 27
May 30, 2017: Theralase Increases Revenue 23% for 1Q 2017 Financial Statements 28
Oct 05, 2016: Theralase Provides Update on ITA Application to Health Canada for TLC-3400 Dosimetry Fibre Optic Cage 31
Oct 05, 2016: Theralase Provides Update on ITA Application to Health Canada for TLC-3200 Photo Dynamic Therapy Laser System 32
Jul 29, 2016: Theralase Files ITA Application to Health Canada for TLC-3400 Dosimetry Fibre Optic Cage 32
Jul 29, 2016: Theralase Files ITA Application to Health Canada for TLC-3200 Photo Dynamic Therapy Laser System 33
Appendix 34
Methodology 34
About GlobalData 36
Contact Us 36
Disclaimer 37

List Of Tables


Theralase Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Theralase Technologies Inc Pipeline Products by Equipment Type 5
Theralase Technologies Inc Pipeline Products by Indication 6
Theralase Technologies Inc Ongoing Clinical Trials by Trial Status 6
Theralase Technologies Inc, Key Facts 7
Theralase Technologies Inc, Major Products and Services 8
Theralase Technologies Inc Number of Pipeline Products by Development Stage 9
Theralase Technologies Inc Pipeline Products Summary by Development Stage 10
Theralase Technologies Inc Ongoing Clinical Trials by Trial Status 11
Theralase Technologies Inc Ongoing Clinical Trials Summary 12
TLC-2000 Therapeutic Medical Laser System - Product Status 13
TLC-2000 Therapeutic Medical Laser System - Product Description 13
TLC-3200 Medical Laser - Product Status 14
TLC-3200 Medical Laser - Product Description 14
TLC-3200 Medical Laser - A Phase Ib Trial of Intravesical Photodynamic Therapy in Patients with Non-muscle Invasive Bladder Cancer at High Risk of Progression who Are Refractory to Bacillus Calmette-guerin Therapy and who are Medically Unfit for/refuse Cystectomy 15
TLC-3400 Medical Laser - Product Status 16
TLC-3400 Medical Laser - Product Description 16
Theralase Technologies Inc, Key Employees 18
Theralase Technologies Inc, Subsidiaries 19
Glossary 35

List Of Figures


Theralase Technologies Inc Pipeline Products by Equipment Type 5
Theralase Technologies Inc Pipeline Products by Development Stage 9
Theralase Technologies Inc Ongoing Clinical Trials by Trial Status 11

Theralase Technologies Inc (TLT) - Product Pipeline Analysis, 2019 Update

Theralase Technologies Inc (Theralase) is a clinical stage pharmaceutical company which specializes in design, development, and manufacturing of laser based technologies used in wide range of bio-destructive and bio-simulative clinical

USD 750 View Report

Theralase Technologies Inc (TLT) - Medical Equipment - Deals and Alliances Profile.

Theralase Technologies Inc (TTI) is a medical equipment company that designs, develops and manufactures laser and laser technology for human, companion animal and equine applications. The company provides products such

USD 250 View Report

Mind Technologies Inc (MIND) - Financial and Strategic SWOT Analysis Review

MIND Technologies Inc (MIND) is a diversified company. The company designs, manufactures and markets marine sonar and seismic equipment, exploration equipment and specialized equipment. It offers seismic source acquisition and

USD 300 View Report

Theralink Technologies Inc (OBMP) - Financial and Strategic SWOT Analysis Review

Theralink Technologies Inc (Theralink), formerly OncBioMune Pharmaceuticals Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The companys products comprise biosimilars and vaccines developed for cancer types such

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available